20050220
 Investor's Calendar   The Wall Street Journal,  Feb 20, 2005  Briefly: Wal-Mart's profit rose 16% last quarter, with sales boosted by new-store openings... Target reported a 5.4% rise in same-store sales but its earnings were flat...Congress passed a bill that makes it easier for defendants to move many class-action lawsuits to federal courts...Merck shares rose 13% Friday after FDA advisers concluded that its painkiller Vioxx and Pfizer's Celebrex and Bextra pose an increased risk for heart problems but should remain on the market because the benefits outweigh risks. A 17-15 vote favored Vioxx, which isn't currently on sale.   
